Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Healthcare Cannabis Psychedelics
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Core One Labs Inc
Bullboard Posts
User Avatar Image
(29)
•••
Comment by bullman246on Jun 12, 2020 5:36pm
164 Views
Post# 31145252

RE:RE:RE:RE:RE:RE:COOL "Plan B" Lack of Accomplishments

RE:RE:RE:RE:RE:RE:COOL "Plan B" Lack of AccomplishmentsVik has told me that Brad setup the company with a non-independent BOD. Therefore, we as majority shareholders cannot vote him out. Only the BOD can fire Brad, and that would be career suicide, since each is beholding to Brad. Avccording to Vik, this is why investors need to take a Plan B legal action.

Have you ever in your wildest imagination heard of a scenario where majority shareholdrers can't vote to fire a CEO in a public company? Where the CEO is answerable to no one? This is corruption and immoral behavior beyond belief.

Vik is notw IR. Have you heard a word from him regarding this latest shady deal? No. In fact, as I stated, Vik supports this deal, and told me that there are better parts to it, but didn't disclose what they are.

Brad seems heel intent on deliberately driving this company into bankruptcy. But why? I still cannot come up with an answer.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities